Literature DB >> 30962570

A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

José-María López-Lozano1, Timothy Lawes2, César Nebot3, Arielle Beyaert4, Xavier Bertrand5,6, Didier Hocquet5,6, Mamoon Aldeyab7, Michael Scott8, Geraldine Conlon-Bingham8, David Farren9, Gábor Kardos10, Adina Fésűs11, Jesús Rodríguez-Baño12,13, Pilar Retamar12,13, Nieves Gonzalo-Jiménez14, Ian M Gould15.   

Abstract

Balancing access to antibiotics with the control of antibiotic resistance is a global public health priority. At present, antibiotic stewardship is informed by a 'use it and lose it' principle, in which antibiotic use by the population is linearly related to resistance rates. However, theoretical and mathematical models suggest that use-resistance relationships are nonlinear. One explanation for this is that resistance genes are commonly associated with 'fitness costs' that impair the replication or transmissibility of the pathogen. Therefore, resistant genes and pathogens may only gain a survival advantage where antibiotic selection pressures exceed critical thresholds. These thresholds may provide quantitative targets for stewardship-optimizing the control of resistance while avoiding over-restriction of antibiotics. Here, we evaluated the generalizability of a nonlinear time-series analysis approach for identifying thresholds using historical prescribing and microbiological data from five populations in Europe. We identified minimum thresholds in temporal relationships between the use of selected antibiotics and incidence rates of carbapenem-resistant Acinetobacter baumannii (Hungary), extended-spectrum β-lactamase-producing Escherichia coli (Spain), cefepime-resistant E. coli (Spain), gentamicin-resistant Pseudomonas aeruginosa (France) and methicillin-resistant Staphylococcus aureus (Northern Ireland) in different epidemiological phases. Using routinely generated data, our approach can identify context-specific quantitative targets for rationalizing population antibiotic use and controlling resistance. Prospective intervention studies that restrict antibiotic consumption are needed to validate these thresholds.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30962570     DOI: 10.1038/s41564-019-0410-0

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  39 in total

1.  Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.

Authors:  J M López-Lozano; D L Monnet; A Yagüe; A Burgos; N Gonzalo; P Campillos; M Saez
Journal:  Int J Antimicrob Agents       Date:  2000-02       Impact factor: 5.283

2.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

3.  Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.

Authors:  Mamoon A Aldeyab; Dominique L Monnet; José María López-Lozano; Carmel M Hughes; Michael G Scott; Mary P Kearney; Fidelma A Magee; James C McElnay
Journal:  J Antimicrob Chemother       Date:  2008-05-07       Impact factor: 5.790

4.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

Authors:  D J Austin; K G Kristinsson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

5.  The population genetics of antibiotic resistance.

Authors:  B R Levin; M Lipsitch; V Perrot; S Schrag; R Antia; L Simonsen; N M Walker; F M Stewart
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

6.  Antibiotic effectiveness: balancing conservation against innovation.

Authors:  Ramanan Laxminarayan
Journal:  Science       Date:  2014-09-12       Impact factor: 47.728

7.  Constraining the use of antibiotics: applying Scanlon's contractualism.

Authors:  Michael Millar
Journal:  J Med Ethics       Date:  2012-03-19       Impact factor: 2.903

8.  Balancing the drug-resistance equation.

Authors:  S B Levy
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

9.  Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community.

Authors:  Nathalie Vernaz; Benedikt Huttner; Daniel Muscionico; Jean-Luc Salomon; Pascal Bonnabry; José Maria López-Lozano; Arielle Beyaert; Jacques Schrenzel; Stephan Harbarth
Journal:  J Antimicrob Chemother       Date:  2011-01-19       Impact factor: 5.790

Review 10.  Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance.

Authors:  L R Peterson
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

View more
  18 in total

1.  Extensively drug-resistant Acinetobacter baumannii carrying blaOXA-23-like and armA in a hospital after an intervention in the intensive care unit which ended a long-standing endemicity.

Authors:  Carlos Rodríguez-Lucas; M Rosario Rodicio; Xenia Vázquez; Dolores Escudero; Brígida Quindós; Miguel Alaguero; Javier Fernández
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-17       Impact factor: 3.267

2.  Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistant Acinetobacter baumannii strains: a time series analysis.

Authors:  Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; Vangelis D Karalis
Journal:  Eur J Hosp Pharm       Date:  2022-03

3.  Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.

Authors:  Mei-Chun Lee; Hsun Chang; Fang-Ju Sun; Alice Ying-Jung Wu; Chien-Hung Lu; Chun-Ming Lee
Journal:  Am J Trop Med Hyg       Date:  2022-06-13       Impact factor: 3.707

4.  Identifying Targets for Antibiotic Use for the Management of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in Hospitals-A Multi-Centre Nonlinear Time-Series Study.

Authors:  Zainab Said Al-Hashimy; Barbara R Conway; Mubarak Al-Yaqoobi; Faryal Khamis; Ghalib Zahran Al Mawali; Aisha Mahad Al Maashani; Yaqoob Said Al Hadhrami; Said Salim Al Alawi; Mohammed Said Al Mamari; William J Lattyak; Elizabeth A Lattyak; Motasem Aldiab; Ian Gould; José-María López-Lozano; Mamoon A Aldeyab
Journal:  Antibiotics (Basel)       Date:  2022-06-07

Review 5.  Uses of mathematical modeling to estimate the impact of mass drug administration of antibiotics on antimicrobial resistance within and between communities.

Authors:  Scott W Olesen
Journal:  Infect Dis Poverty       Date:  2022-06-30       Impact factor: 10.485

Review 6.  Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.

Authors:  Gang Chen; Kailiang Xu; Fangyuan Sun; Yuxia Sun; Ziyuan Kong; Bangjiang Fang
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-06-30       Impact factor: 2.471

7.  Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018.

Authors:  Shuangshuang Zeng; Zhijie Xu; Xiang Wang; Wanli Liu; Long Qian; Xi Chen; Jie Wei; Minwen Zhu; Zhicheng Gong; Yuanliang Yan
Journal:  Infect Drug Resist       Date:  2019-08-28       Impact factor: 4.003

8.  Impact of antibiotic usage on extended-spectrum β-lactamase producing Escherichia coli prevalence.

Authors:  Jeong Yeon Kim; Yunjin Yum; Jong Hun Kim; Jang Wook Sohn; Hyung Joon Joo; Hyonggin An; Young Kyung Yoon
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

9.  Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents.

Authors:  Miklos Fuzi; Jesus Rodriguez Baño; Akos Toth
Journal:  Front Microbiol       Date:  2020-02-25       Impact factor: 5.640

10.  Geographical information system and spatial-temporal statistics for monitoring infectious agents in hospital: a model using Klebsiella pneumoniae complex.

Authors:  Priscila Pinho da Silva; Fabiola A da Silva; Caio Augusto Santos Rodrigues; Leonardo Passos Souza; Elisangela Martins de Lima; Maria Helena B Pereira; Claudio Neder Candella; Marcio Zenaide de Oliveira Alves; Newton D Lourenço; Wagner S Tassinari; Christovam Barcellos; Marisa Zenaide Ribeiro Gomes
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-16       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.